Nikhil Prasad Fact checked by:Thailand Medical News Team Nov 16, 2024 1 month, 6 hours, 15 minutes ago
Medical News: Alzheimer’s disease (AD), a devastating neurodegenerative condition, affects millions globally, causing memory loss, cognitive decline, and behavioral changes. Its pathology is marked by the build-up of amyloid-beta (Aβ) plaques and neurofibrillary tangles of hyperphosphorylated tau protein. For years, researchers have explored various mechanisms driving AD, and oxidative stress has emerged as a key factor. Oxidative stress occurs when the body’s ability to neutralize reactive oxygen species (ROS) is overwhelmed. This
Medical News report explores a fascinating aspect of AD - the role of NADPH oxidase (NOX) enzymes, which are major producers of ROS.
Alzheimer’s Disease and the Role of NADPH Oxidase Enzymes
A team of researchers from Soonchunhyang Institute of Medi-Bio Science and Soonchunhyang University College of Medicine in the Republic of Korea delved into the molecular contributions of NOX enzymes to AD. They emphasize that understanding the distinct functions of NOX isoforms could pave the way for innovative treatments targeting these enzymes.
The NOX Family and Its Functions
The NOX family comprises seven isoforms: NOX1, NOX2, NOX3, NOX4, NOX5, and dual oxidases DUOX1 and DUOX2. These enzymes generate ROS as part of normal physiological processes. However, their overactivity can lead to cellular damage, particularly in the brain. Each isoform has unique structural and functional attributes, making them intriguing targets for AD research.
-NOX1 and NOX2: Oxidative Stress Amplifiers
NOX1 and NOX2 are key contributors to oxidative stress in AD. NOX1, which is activated by regulatory proteins NOXO1 and NOXA1, is associated with chronic oxidative stress in neurons. Elevated NOX1 levels have been found in early-stage AD brains, suggesting its role in the disease's onset.
NOX2, on the other hand, is predominantly expressed in microglia and neurons. It is activated by Aβ plaques, leading to ROS production and the release of pro-inflammatory cytokines like IL-1β and TNF-α. This vicious cycle exacerbates synaptic damage and accelerates cognitive decline.
-NOX3 and NOX4: Emerging Players
NOX3, though less studied, has been detected in AD brains. It generates superoxide, a type of ROS, contributing to oxidative damage. NOX4, unique for its ability to produce hydrogen peroxide independently of regulatory proteins, has been linked to neuronal tau pathology and astrocytic ferroptosis - a type of programmed cell death. Elevated NOX4 levels correlate with hallmark AD features, such as tau hyperphosphorylation.
-NOX5, DUOX1, and DUOX2: New Horizons
NOX5, distinct for its calcium-dependent activation, is implicated in blood-brain barrier disruption and cognitive impairment. Studies using animal models reveal that NOX5 contributes to oxidative stress and memory deficits. Similarly, DUOX1 and DUOX2, with their peroxidase-like domains, are increasingly associated with age-rel
ated neurodegeneration.
Key Study Findings
The researchers discovered several intriguing insights into NOX enzymes and their roles in AD:
-NOX2 and Inflammation: Activation of NOX2 by Aβ plaques leads to a cascade of neuroinflammation, driving the production of cytokines that worsen AD pathology. Inhibiting NOX2 activity reduced oxidative stress and improved cognitive outcomes in animal models.
-NOX4 and Tau Pathology: NOX4’s ability to generate ROS contributes to tau protein abnormalities, a hallmark of AD. Reducing NOX4 expression alleviated neuronal damage and improved memory in experimental setups.
-NOX Isoforms and AD Progression: While NOX2 and NOX4 are heavily implicated, other isoforms like NOX1, NOX3, and NOX5 are gaining attention. NOX3's superoxide production and NOX5's role in blood-brain barrier integrity highlight their potential significance.
-DUOX Enzymes in Aging: DUOX1 and DUOX2 are elevated in aged brains, suggesting their involvement in the oxidative stress seen in AD. Animal models showed that reducing DUOX activity mitigated neurodegeneration.
Therapeutic Implications
Targeting NOX enzymes offers a promising strategy for AD treatment. Current inhibitors like apocynin and GKT137831 show potential in reducing oxidative stress and inflammation. However, the challenge lies in developing isoform-specific inhibitors to avoid off-target effects.
For instance, apocynin, which interferes with NOX subunit interactions, has demonstrated neuroprotective effects in AD models. Similarly, GKT137831 selectively inhibits NOX1 and NOX4, showing promise in clinical trials. Novel approaches like NOX2ds-tat, a peptide inhibitor, have successfully reduced oxidative damage and improved brain function in animal studies.
Conclusion
The findings underscore the pivotal roles of NOX enzymes in AD, particularly NOX2 and NOX4. These enzymes not only drive oxidative stress but also exacerbate neuroinflammation and neuronal damage. Developing specific inhibitors for NOX isoforms could revolutionize AD treatment, offering hope for slowing or even halting disease progression. Future research should explore the potential of other NOX isoforms, such as NOX5 and DUOX enzymes, to create a comprehensive therapeutic strategy.
The study findings were published in the peer-reviewed International Journal of Molecular Sciences.
https://www.mdpi.com/1422-0067/25/22/12299
For the latest on Alzheimer research, keep on logging to Thailand
Medical News.
Read Also:
https://www.thailandmedical.news/news/neural-stem-cell-therapy-shows-promise-in-brain-restoration-and-alzheimer-s-disease
https://www.thailandmedical.news/news/thyroid-hormone-shows-promise-in-reversing-alzheime-s-like-symptoms
Share
Tweet
Share
